Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: A double-blind placebo and bupropion-controlled study

Autor:	Paul Thuras, Timothy D. Folsom, S. Hossein Fatemi, Mahtab K Yousefi, Stephanie B. Liesch, Rachel E. Kneeland
Rok vydání:	2013
Předmět:	Male medicine.medical_specialty medicine.medical_treatment MEDLINE Schizoaffective disorder Placebo law.invention chemistry.chemical_compound Double-Blind Method Randomized controlled trial law Quinoxalines Humans Medicine Nicotinic Agonists Psychiatry Varenicline Antipsychotic Bupropion Biological Psychiatry Psychiatric Status Rating Scales business.industry Smoking Benzazepines medicine.disease Psychiatry and Mental health Psychotic Disorders chemistry Schizophrenia Antidepressive Agents Second-Generation Female business Antipsychotic Agents Follow-Up Studies medicine.drug
Zdroj:	Schizophrenia Research. 146:376-378
ISSN:	0920-9964
DOI:	10.1016/j.schres.2013.02.015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39a97d800dff4f50ca2cc43e3a1dda20 https://doi.org/10.1016/j.schres.2013.02.015 Zobrazit plný text záznamu Full Text from ScienceDirect